Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperpolarized Xenon-129 Functional Magnetic Resonance Imaging of Healthy Volunteers and Participants With Alzheimer's Disease

NCT02638519 is registered in ClinicalTrials.gov with Thunder Bay Regional Health Research Institute as lead sponsor.

NCT NCT02638519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02638519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperpolarized Xenon-129 Functional Magnetic Resonance Imaging of Healthy Volunteers and Participants With Alzheimer's Disease
Lead sponsor
Thunder Bay Regional Health Research Institute
Phase
Phase 1
Overall status
Terminated
Start date
June 27, 2016
Completion date
April 19, 2022
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease